Additional therapeutic strategies to restore tumor suppressor function could be related to the modulation of SALL1 or SALL2 protein levels by altering their ubiquitylation and subsequent proteasome degradation, or by inhibiting still unknown negative regulators of the transcription factor expression. Here, SALL2 is linked to neoplasm.